Next Quarterly Earnings
Monday, November 30, 2026
CW 49
After-Hours
In 48 days
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for rare and prevalent diseases. Utilizing RNA interference (RNAi), Arrowhead develops medicines that modulate gene expression at the molecular level, aiming to treat diseases at their root. Arrowhead Pharmaceuticals is a leading innovator in the development of RNAi-based medicines.
Frequently asked questions
When will Arrowhead Pharmaceuticals report its next quarterly earnings?
Arrowhead Pharmaceuticals is scheduled to report its next quarterly earnings on 11/30/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
When did Arrowhead Pharmaceuticals last report quarterly earnings?
Arrowhead Pharmaceuticals last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -1.36 USD.
How does Arrowhead Pharmaceuticals stock react to earnings?
Across its last 5 earnings reports, Arrowhead Pharmaceuticals stock moved by ±7.7% on average the following day. The largest reaction was +23.3% on 11/25/2025; 1 of 5 reactions were positive.
How often has Arrowhead Pharmaceuticals beaten expectations?
Arrowhead Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
How do I add the Arrowhead Pharmaceuticals earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
In the earnings calendar
Earnings statistics
Stock reaction to earnings
±7.7%
Avg. next-day move
+23.3%
Largest move (11/25/2025)
20%
Share of positive reactions
±6.5%
Avg. move after 7 days
Basis: price reactions to the last 5 report dates (close to close).
Estimates vs. results
2/5
Quarters above estimates
40%
Beat rate
+100%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Arrowhead Pharmaceuticals
Country
🇺🇸
More Financial Information